DGAP-News: ​​​​​​​Epigenomics AG Reports Financial Results for the First Six Months of 2022

Berlin (Germany) and San Diego, CA (U.S.A.), August 10, 2022 - Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the "Company") today reported financial results (IFRS, unaudited) for the second quarter and first half of 2022.